An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 6c30 that has a similar product distributed in the us, list number 6l21.
|
The complaint investigation for a false non-reactive result for one sample tested with the architect havab igm assay lot 10346be01 included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review.Inhouse retained kit testing for sensitivity could not be performed as reagent lot had been expired when complaint investigation was performed.Trending review determined no trends for the issue for the product.Manufacturing documentation for the likely cause lot did not identify any issues associated with the complaint issue.Based on our investigation, no systemic issue or deficiency with the architect havab igm reagent lot 10346be01 was identified in the complaint.
|